Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach

Ähnliche Einträge

• Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects
  von: Susanne Bonsmann, et al.
  Veröffentlicht: (2024)
• Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Pritelivir and Its Metabolites
  von: Katharina Erb‐Zohar, et al.
  Veröffentlicht: (2024)
• Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
  von: Shichang Miao, et al.
  Veröffentlicht: (2024)
• Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P–Glycoprotein Inhibition
  von: Hongxia Jia, et al.
  Veröffentlicht: (2025)
• Lack of Pharmacokinetic Drug–Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs
  von: Kelong Han, et al.
  Veröffentlicht: (2025)